Pfizer could have working Covid-19 vaccine before the end of 2020

Share

The comments follow rival AstraZeneca's COVID-19 vaccine trials being put on hold worldwide on September 6 after a serious side effect was reported in a volunteer in Britain.

Aiming to protect essential workers and reduce the likelihood of a resurgence, the vaccines are also grabbing attention in the global scramble by governments to secure supplies, potentially helping reframe China's perceived role in the pandemic.

The late-stage clinical trial for AstraZeneca's COVID-19 vaccine will be suspended in the USA for at least several more days, Reuters reported Monday, citing a source familiar with the matter.

A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up. In June, China's military approved a vaccine for use within its ranks developed by its research unit and a biotech firm.

"Clinical trials for the third phase are continuing under the strict supervision of medical teams, while following all measures to control the quality, safety and efficacy of the vaccine", said NCEMA.

Gareth Bale: Manchester United and Tottenham offered Real Madrid winger
Bale has won four Champions League titles with Real, but he has a reputation for uninterestedness as well as poor fitness. They are also aware that any loan would just see an unwanted player return at less value than before, given his age.

Because the study is randomized, double-blind and placebo-controlled - the gold-standard of clinical trials - researchers do not know if the subject received the experimental jab or a placebo. "The last thing you want to do is hurt healthy people".

Russian Federation is one of the few other countries to authorise the use of an experimental vaccine, making its own "Sputnik V" vaccine mandatory for certain groups including teachers.

South Korea will buy 20 million doses of vaccine from the COVAX scheme, enough for 10 million people, and 40 million doses from private drug-makers, health authorities said in a statement.

Company CEO Albert Bourla has said it is "likely" the U.S. will get a coronavirus vaccine treatment to the public before the end of the year. The company has planned to expand into Japan and Russian Federation for the early to mid-stage trials. In August, Russia's Minister of Trade and Industry Denis Manturov claimed that the country would produce a thousand doses of vaccine per month before the end of the year. "One thing wrong about the western countries; it's all profit, profit, profit".

Share